Blog
RSS FeedPosted by Michael Wonder on 02 Feb 2025
Public consultation: draft 2025-26 cost recovery implementation statement for listing medicines on the PBS and designated vaccines on the NIP
31 January 2025 - Consultation on the draft 2025-26 cost recovery implementation statement for listing medicines on the PBS and ...
Posted by Michael Wonder on 02 Feb 2025
Cheaper medicine for lung cancer patients
2 February 2025 - The Australian Government is listing Retevmo (selpercatinib) on the PBS for the first time to treat advanced ...
Posted by Michael Wonder on 01 Feb 2025
Bupa and Healthscope end battle over hospital payments, meaning no gap fees for stays
31 January 2025 - Millions of Bupa customers will avoid incurring gap fees for stays at Healthscope hospitals after the ...
Posted by Michael Wonder on 01 Feb 2025
Schedule of Pharmaceutical Benefits - 1 February 2025
1 February 2025 - The February 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Jan 2025
Outcomes from the December 2024 PBAC meeting
31 January 2025 - Recommendations made by the PBAC in December 2024 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 29 Jan 2025
Von Hippel-Lindau disease drug Welireg listed on PBS slashing cost by $11,000 a month for patients
28 January 2025 - The treatment for Simon Goodrich’s disease has been costing $12,000 a month, but there has been a ...
Posted by Michael Wonder on 28 Jan 2025
Apellis receives approval of Syfovre (pegcetacoplan) in Australia for geographic atrophy
27 January 2025 - Apellis Pharmaceuticals announced today that the TGA has approved Syfovre (pegcetacoplan) for the every-other-month treatment of adult ...
Posted by Michael Wonder on 24 Jan 2025
Australia’s TGA approves registration of CSL’s Andembry (garadacimab) for the prevention of recurrent hereditary angioedema attacks
24 January 2025 - This regulatory approval for registration in Australia is the first in the world for Andembry. ...
Posted by Michael Wonder on 21 Jan 2025
Drug shortage crisis demands intervention, AMA warns, as patients struggle to secure medicines
20 January 2025 - There are more than 400 medicine shortages, and the country’s leading medical group blames it on ‘ad ...
Posted by Michael Wonder on 20 Jan 2025
Australians benefit from freeze to maximum cost of PBS medicines
20 January 2025 - The Australian Government has launched an advertising campaign to raise awareness about a freeze on the maximum ...
Posted by Michael Wonder on 19 Jan 2025
Protection against RSV for mums and bubs with free vaccine available from 3 February
19 January 2025 - From 3 February 2025, Australian mums and their newborn babies will have free access to the best ...
Posted by Michael Wonder on 19 Jan 2025
Junshi Biosciences announces toripalimab’s approval in Australia
17 January 2025 - Shanghai Junshi Biosciences announced that toripalimab, the anti-PD-1 monoclonal antibody self-developed by the company, has obtained the ...
Posted by Michael Wonder on 13 Jan 2025
Peter’s prostate cancer diagnosis came as a shock. Now, he wants to protect his kids.
14 January 2025 - Peter had no symptoms when he was diagnosed with prostate cancer. Now, he’d like to see an ...
Posted by Michael Wonder on 06 Jan 2025
Price must be right to put obesity pill on the PBS
6 January 2025 - Whether to fully subsidise the new generation weight loss drugs such as Mounjaro and Ozempic for ...
Posted by Michael Wonder on 06 Jan 2025
Global pharma giants push for weight loss drugs to be added to PBS
6 January 2025 - Taxpayers would fund popular weight loss drugs for people with severe obesity under a proposal from ...